Category Archives: AZBio News
Phoenix-Based Nonprofit, Focus on Lyme – Breakthrough in Lyme Disease Testing: New Diagnostic Tool Boasts Over 90% Accuracy
Focus on Lyme and Tulane University License Groundbreaking Diagnostic Technology to Aces Diagnostics Inc.Continue reading
Stephenson Prize for Innovation in Pancreatic Cancer Research Launched With $150 Million Gift to City of Hope
LOS ANGELES — City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and ranked among the nation’s top 5 cancer centers by U.S. News & World Report, has received a historic $150 million gift from entrepreneurs and philanthropists A. Emmet Stephenson Jr. and his daughter Tessa Stephenson Brand to immediately fund pancreatic cancer research. Continue reading
Ivy Brain Tumor Center’s Dr. Nader Sanai Named Arizona Bioscience Researcher of the Year
PHOENIX, ARIZ, September 17, 2024 – Dr. Nader Sanai, Director of the Ivy Brain Tumor Center, Chief of Neurosurgical Oncology at Barrow Neurological Institute, and the Francis & Dionne Professor of Neurological Surgery, has been recognized as the 2024 Arizona Bioscience Researcher of the Year by the Arizona Bioindustry Association. He will receive the award at the 20th Annual AZBio Awards on Wednesday, September 18 at the Phoenix Convention Center. Dr. Sanai is being honored for his pioneering spirit and commitment to push beyond the status quo to discover new therapies for his brain tumor patients. Continue reading
Castle Biosciences’ Chief Operating Officer Kristen Oelschlager Named Arizona Bioscience Leader of the Year
PHOENIX and FRIENDSWOOD, TX – Sept. 16, 2024 – The Arizona Bioindustry Association, Inc. (AZBio) and Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Kristen Oelschlager, R.N., Castle’s chief operating officer, has been named the 2024 Jon W. McGarity Arizona Bioscience Leader of the Year. The award, presented by AZBio, recognizes Oelschlager for her outstanding leadership that has contributed significantly to the progression of the bioscience industry in Arizona.Continue reading
C-Path’s Inaugural Global Impact Conference Charts the Future of Drug Development
WASHINGTON, Sept. 12, 2024 — Critical Path Institute (C-Path) successfully concluded its inaugural Global Impact Conference (CGIC) on September 11, 2024, at the Washington Marriott at Metro Center in Washington, D.C. This landmark event brought together industry leaders, regulatory agencies, academic experts, and patient advocacy groups, all dedicated to advancing drug development and regulatory science for rare diseases. Continue reading
Macula Vision Systems Shines in Prestigious Global Competitions, State Accelerator and Bioscience Entrepreneurship Program
Tucson, AZ — University of Arizona Center for Innovation (UACI) is proud to announce that Macula Vision Systems, a pioneer in clinical microscopy, continues to gain momentum as it advances in both national and international stages of the life sciences industry. Macula Vision Systems is based out of UACI at Oro Valley, Arizona – an incubator focused on supporting bioscience startups by providing specialized lab space and tailored business development programming. In recent and upcoming weeks, the company proudly stands out by participating in prestigious programs and pitch competitions, highlighting its groundbreaking advancements in high-throughput imaging and automated interpretation technologies.Continue reading
GT Medical Technologies, Inc. Secures $35 Million Venture Loan Facility from Horizon Technology Finance
TEMPE, Ariz., Sept. 12, 2024 /PRNewswire/ — GT Medical Technologies, Inc. (“GT MedTech” or the “Company”), a medical device company with a corporate purpose of improving the lives of patients with brain tumors, today announced it has secured a $35 million venture loan facility, of which $15 million has been initially funded from Horizon Technology Finance Corporation (NASDAQ: HRZN), an affiliate of Monroe Capital.Continue reading
TGen launches Center for Spatial Multi-Omics (COSMO): A Service Center dedicated to transforming biomedical research through spatial biology
PHOENIX, AZ (September 11, 2024) – The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the launch of the Center for Spatial Multi-Omics (COSMO), a service center dedicated to transforming biomedical research through spatial biology. COSMO offers an unparalleled suite of services designed to help scientists visualize and map molecular data at the single-cell level directly within tissues.Continue reading